Besides, based on the reports of miRNA-based regulation of ACVR1 [26, 36], understanding the underlying mechanisms of the ACVR1 gene biology may offer potential therapeutic drug target in glaucoma. This evidence concerns the gene ACVR1 and glaucoma.